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Résumé en
anglais
BACKGROUND: Huntington's disease (HD) is one of several neurodegenerative
disorders that have been associated with metabolic alterations. Changes in Insulin
Growth Factor 1 (IGF-1) and/or insulin input to the brain may underlie or contribute
to the progress of neurodegenerative processes. Here, we investigated the association
over time between changes in plasma levels of IGF-1 and insulin and the cognitive
decline in HD patients.
METHODS: We conducted a multicentric cohort study in 156 patients with genetically
documented HD aged from 22 to 80 years. Among them, 146 patients were assessed
at least twice with a follow-up of 3.5 ± 1.8 years. We assessed their cognitive decline
using the Unified Huntington's Disease Rating Scale, and their IGF-1 and insulin
plasmatic levels, at baseline and once a year during the follow-up. Associations were
evaluated using a mixed-effect linear model.
RESULTS: In the cross-sectional analysis at baseline, higher levels of IGF-1 and
insulin were associated with lower cognitive scores and thus with a higher degree of
cognitive impairment. In the longitudinal analysis, the decrease of all cognitive
scores, except the Stroop interference, was associated with the IGF-1 level over time
but not of insulin.







Autre titre PLoS ONE
Identifiant


































Publié sur Okina (http://okina.univ-angers.fr)
